Case Study 2 — Four People Sold Personalization: When It Was Right, and When It Was a Product

⚠️ Four illustrative composites, three of whom are established canon. ⚠️ This case study exists because §35.7 draws a line between personalization that is medicine and personalization that is a product, and the line is much easier to see in four people than in a table.**

The premise

⚠️ Four people were told that a standard diet would not suit them and that they needed something individual.

⚠️ In two cases that was true, medically established, and free. ⚠️ In one it was true and the product was still the wrong way to find out. ⚠️ In one it was a product with nothing behind it.

Person 1 — Alma Ortiz

(Canon since Chapter 1. Seven years old. Peanut allergy — Chapter 28.)

⚠️ This is what real personalized nutrition looks like, and it is worth noticing how unlike the products it is.

⚠️ It came from a clinical pathway, not a consumer test. ⚠️ It concerns one substance, not a lifestyle. ⚠️ It has a mechanism, a diagnostic standard, and a management plan with an emergency component. ⚠️ And nobody sells the Ortiz-Lindqvists a subscription for it.

⚠️ The most consequential dietary personalization in this entire book was established by a clinician asking questions and confirming them, and it cost nothing.

⚠️ And the contrast that matters: ⚠️ Marisol was also offered, repeatedly, an IgG "food sensitivity" panel for Alma — advertised as finding hidden sensitivities the allergy testing missed.

⚠️ ❌ Not supported (Chapter 28 §28.13). ⚠️ Had she bought it, it would have returned a list of foods to remove from the diet of a child who already has one genuine and serious restriction — which is a harm, not merely a waste.

Person 2 — Walt Prosser

(Canon since Chapter 4. The nine supplements, the biotin–troponin ER episode — Chapter 16. Type 2 diabetes — Chapter 26.)

⚠️ Walt is the person in this book for whom continuous glucose monitoring is genuinely indicated, and that is not a coincidence worth passing over.

⚠️ The technology in §35.5 was developed for people like Walt, works for people like Walt, and has outcome evidence in people like Walt. ⚠️ The consumer market extended it to people who are not Walt, and the evidence did not come along.

⚠️ What he was ALSO sold, and this is the point of including him:

⚠️ A DTC micronutrient panel that returned several results at the edges of reference ranges, each accompanied by a supplement recommendation. ⚠️ Three of the nine supplements in his Chapter 16 audit originated this way.

⚠️ The same person can have genuine, evidence-based personalization AND be sold three products on the back of a test that generated findings within normal variation.

⚠️ Having a real condition makes you a better customer, not a more protected one.

Person 3 — Priya Achterberg

(Introduced Chapter 15. Recreational marathon runner.)

⚠️ Two things about her report are worth separating carefully, because they are frequently confused.

⚠️ The report was not USELESS. It was CIRCULAR.

⚠️ It told her she suited endurance training, which she already knew from four years of doing it. It told her carbohydrate suited her, which Chapter 23 tells every endurance athlete. ⚠️ It felt accurate because it described her, and it described her because those things are true of most endurance runners.

⚠️ A report that tells you what you already know feels like validation and functions like a horoscope.

⚠️ The one actionable claim — slow caffeine metabolism, limit intake — was the one she acted on, and it is §35.3's 🟡 row.

⚠️ The variant is real and the metabolic difference is real. ⚠️ What is thin is the evidence that acting on it changes anything, and she had roughly fifteen years of her own data on how caffeine affects her sleep, which she had never systematically considered.

⚠️ What actually helped her, and it cost nothing: ⚠️ Chapter 15's work on her sweat rate and her iron status, and Chapter 23's carbohydrate periodization — personalization based on measured physiology and training load rather than on a genotype panel (§35.7's athletic-demand row).

⚠️ Her ferritin was the individualized finding that mattered. It came from a blood test her GP ordered for a symptom.

Person 4 — Corinne Bettancourt

(Introduced Chapter 28. Long-standing gastrointestinal symptoms, no diagnosis for years.)

⚠️ Corinne is the reason §35.12 is in the chapter, and hers is the case most likely to be recognized by a reader.

⚠️ She was not credulous. She had real symptoms, a long diagnostic delay, and no answers — ⚠️ and into that gap arrived three products, each offering a personalized explanation and each generating a list of foods to remove.

⚠️ What happened cumulatively:

⚠️ The diet narrowed and never widened. ⚠️ Each report added exclusions and none removed any. ⚠️ Social eating became difficult, then avoided. ⚠️ And the symptoms did not resolve, which was interpreted as evidence that she had not yet found the right restriction.

⚠️ That interpretation is the trap, and it is structural rather than accidental.

⚠️ A framework in which failure means "you have not eliminated enough yet" cannot be falsified by any amount of not getting better.

⚠️ What eventually helped: ⚠️ a gastroenterology referral, a coeliac screen done properly BEFORE gluten was removed (Chapter 28 §28.6), and a supervised low-FODMAP protocol WITH ITS REINTRODUCTION PHASE (Chapter 27 §27.11) — ⚠️ the phase the commercial programmes had never included, and the one that establishes what a person can actually eat.

⚠️ The clinical route personalized her diet more, and narrowed it less, than three consumer products had over three years.

⚠️ The comparison

⚠️ In all four cases, what helped was measured, clinical, and either free or cheap.

⚠️ In all four cases, something unevidenced was also sold — including to the two people whose personalization was completely genuine.

Analysis

1. ⚠️ The two genuine personalizations came from clinical pathways and cost nothing. ⚠️ §35.7's list is not a consolation prize — it is where the evidence is.

2. ⚠️ Walt is the person for whom §35.5's technology is indicated, ⚠️ and the consumer market extended it to everyone who is not Walt without the evidence following.

3. ⚠️ Having a real condition made Walt a better customer, not a protected one. ⚠️ Three of his nine supplements came from a test that found normal variation.

4. ⚠️ Priya's report was circular rather than wrong — ⚠️ it described her accurately by describing most endurance runners, which is how a horoscope works.

5. ⚠️ Her one genuinely individualized finding was a ferritin result from a GP acting on a symptom.

6. ⚠️ Corinne's diet narrowed cumulatively across three disagreeing reports and never widened — ⚠️ which is Chapter 34 §34.9's pattern arriving through a commercial channel rather than a psychological one.

7. ⚠️ Her framework was unfalsifiable. ⚠️ "You have not eliminated enough yet" cannot be disconfirmed by continuing not to get better, and that is a property of the framework, not of her.

8. And the clinical route personalized her diet MORE and narrowed it LESS — ⚠️ because it included the reintroduction phase, which is the part that establishes what someone can eat rather than what they cannot.

Discussion Questions

1. ⚠️ The most consequential personalization in this book — Alma's — was free and came from a clinician asking questions. Why does that not feel like "personalized nutrition"? ⚠️ What has the term come to mean, and who benefits from that meaning?

2. ⚠️ Walt has a real condition and was still sold three unevidenced supplements. What protects a patient from being a customer?

3. ⚠️ Priya's report was accurate and circular. ⚠️ How would you tell the difference in a report about yourself? Design a test.

4. ⚠️ Corinne's framework could not be falsified. ⚠️ Find two other unfalsifiable frameworks in this book. (Chapters 17 and 21 each have one.)

5. ⚠️ Three products disagreed and she added all three sets of exclusions. Why is cumulative restriction the default response to disagreement? ⚠️ What would a person have to believe to subtract instead?

6. ⚠️ The reintroduction phase was the part no commercial programme included. ⚠️ Why would a product omit the phase that ends the restriction? Answer commercially, not charitably.

Your Turn

Step 1 — ⚠️ List your own genuine personalizations, from §35.7.

⚠️ Diagnosed allergy or coeliac disease: __ ⚠️ Diagnosed intolerance: __ ⚠️ Diagnosed conditions: __ ⚠️ Medications and interactions: __ ⚠️ Life stage: __ ⚠️ Training load: __ ⚠️ Documented deficiencies: __ ⚠️ Budget, kitchen, schedule, household, culture, preference: __

⚠️ Count how many required a consumer test. For most readers the answer is none.

Step 2 — ⚠️ The circularity check. Take any personalized report you have.

⚠️ Cover the "personalized" framing and read the recommendations alone. ⚠️ Could they have been written by someone who knew only your age, sex, activity level and one sentence about your diet? ____

⚠️ If yes, that is Priya's report.

Step 3 — ⚠️ The narrowing audit.

⚠️ How many foods have you removed on the basis of a test, a report or an app? _ ⚠️ How many have you ever added BACK? _

⚠️ If the second number is zero and the first is not, that is Corinne's trajectory, and Chapter 27 §27.11's reintroduction phase is what is missing.

Step 4 — ⚠️ Find the unfalsifiable claim.

⚠️ In whatever framework you are using: what result would prove it wrong? __

⚠️ If you cannot answer, that is the finding.

Step 5 — ⚠️ And before buying anything, ask the clinical question first.

⚠️ "Is there a diagnosis that would explain this, and has anyone looked?"

⚠️ Corinne spent three years and over $2,000 before anyone did.